Covid-19 pandemic: Proportion of youth infected with virus triples in five months, says WHO

Young people who are hitting nightclubs and beaches are leading a rise in fresh coronavirus cases across the world, with the proportion of those aged 15 to 24 who are infected rising three-fold in about five months, the World Health Organization said.

An analysis by the WHO of 6 million infections between Feb. 24 and July 12 found that the share of people aged 15-24 years rose to 15% from 4.5%.

Apart from the United States which leads a global tally with 4.8 million total cases, European countries including Spain, Germany and France, and Asian countries such as Japan, have said that many of the newly infected are young people.

“Younger people tend to be less vigilant about masking and social distancing,” Neysa Ernst, nurse manager at Johns Hopkins Hospital’s biocontainment unit in Baltimore, Maryland told Reuters in an email.

“Travel increases your chances of getting and spreading COVID-19,” she said, adding young people are more likely to go to work in the community, to a beach or the pub, or to buy groceries.

The surge in new cases, a so-called second wave of infections, has prompted some countries to impose new curbs on travel even as companies race to find a vaccine for the fast-spreading virus that has claimed more than 680,000 lives and upended economies.

Even countries such as Vietnam, widely praised for its mitigation efforts since the coronavirus appeared in late January, are battling new clusters of infection.

Among those aged 5-14 years, about 4.6% were infected, up from 0.8%, between Feb. 24 and July 12, the WHO said, at a time when testing has risen and public health experts are concerned that reopening of schools may lead to a surge in cases.

Anthony Fauci, the leading U.S. expert on infectious diseases, urged young people last month to continue to socially distance, wear masks and avoid crowds, and cautioned that asymptomatic people could spread the virus, too.

Indeed, health experts in several countries have urged similar measures as they report that infected youth show few symptoms.

“We’ve said this before and we’ll say it again: young people are not invincible,” WHO Director General Tedros Adhanom Ghebreyesus told a news briefing in Geneva last week.

“Young people can be infected; young people can die; and young people can transmit the virus to others.”

Last month, Tokyo officials said they would conduct coronavirus testing in the city’s nightlife districts, and instructed nightclubs to provide customers with enough space with good ventilation and to ask them to avoid speaking loudly.

In France last month, authorities shut down a bar where people breached hygiene rules and caused an outbreak.

(This story has been published from a wire agency feed without modifications to the text. Only the headline has been changed.)

Follow more stories on Facebook and Twitter

Source: Read Full Article

Experts make weak recommendation for remdesivir in severe COVID-19

In The BMJ today, a panel of international experts make a weak recommendation for the use of remdesivir in patients with severe covid-19, and strongly support continued enrolment of patients into ongoing clinical trials of remdesivir.

Their advice is part of The BMJ‘s Rapid Recommendations initiative—to produce rapid and trustworthy guidelines for clinical practice based on new evidence to help doctors make better decisions with their patients.

The antiviral medication remdesivir has received worldwide attention as a potentially effective treatment for severe covid-19 and is already being used in clinical practice.

Today’s recommendation is based on a new evidence review comparing the effects of several drug treatments for covid-19 up to 20 July 2020.

It shows that remdesivir may be effective in reducing recovery time in patients with severe covid-19, although the certainty of the evidence is low. But remdesivir probably has no important effect on the need for mechanical ventilation and may have little or no effect on length of hospital stay.

The authors stress that “the effectiveness of most interventions is uncertain because most of the randomised controlled trials so far have been small and have important study limitations.”

After thoroughly reviewing this evidence, the expert panel says that most patients with severe covid-19 would likely choose treatment with remdesivir given the potential reduction in time to clinical improvement.

But given the low certainty evidence, and allowing for different patient perspectives, values, and preferences, they issued a weak recommendation with strong support for continued recruitment in trials.

They suggest that future research should focus on areas such as optimal dose and duration of therapy, and whether there are specific groups of patients most likely to benefit from remdesivir.

The authors also sound a note of caution about the potential opportunity cost of using remdesivir while the evidence base is still uncertain. As a relatively costly drug that is given intravenously, use of remdesivir may divert funds, time, attention, and workforce away from other potentially worthwhile treatments.

The study that today’s recommendation is based on is called a living systematic review.

In a linked editorial, The BMJ editors explain that living systematic reviews are useful in fast moving research areas such as covid-19 because they allow authors to update previously vetted and peer reviewed evidence summaries as new information becomes available.

Source: Read Full Article

In nation’s 2 largest metros, Blacks and Latinos are more likely to die from COVID-19

A study published today by the UCLA Latino Policy and Politics Initiative found that Latino and Black residents of Los Angeles County and New York City are roughly twice as likely as white residents to die from COVID-19. The research also revealed that high-poverty neighborhoods in both regions have the highest rates of COVID-19 cases and COVID-19–related deaths.

Sonja Diaz, founding director of the policy initiative, said two significant reasons for those trends are that low-income Black and Latino people in both regions tend to have a greater need to work outside of the home and a greater reliance on public transportation, both of which put them at a greater risk for exposure to the coronavirus.

“We are now seven months into the pandemic, and we are starting to have clear information about the disproportionate health and economic impacts that communities of color are facing,” Diaz said. “It’s time to address the specific ways that COVID-19 hurts Latino and Black families and to protect our most vulnerable communities as the virus surges across the nation.”

In Los Angeles County, the age-adjusted death rate was 54 per 100,000 for Latino residents and 46 per 100,000 for Black residents, compared to 23 per 100,000 for white residents; in New York City, the age-adjusted death rates were 247 per 100,000 for Latino residents, 237 per 100,000 for Black residents and 120 per 100,000 for white residents.

The authors recommend that six measures be implemented immediately in cities with large populations of vulnerable communities:

  • Increase testing for low-income communities of color.
  • Provide access to health services and healthy food in low-income communities.
  • Add protections on public transportation, including providing hand sanitizing stations and free masks.
  • Expand access to health care and paid sick leave for essential workers.
  • Increase access to telehealth for low-income residents and the uninsured to bridge the lack of medical care.
  • Ensure that accurate race and ethnicity information is being collected so that elected officials and public health experts can understand the impact of COVID-19 in communities of color.

The researchers analyzed data from Los Angeles County and New York City, two areas that have been hard-hit during the pandemic and are home to large Latino and Black populations. They found that residents who didn’t have health insurance, lived in overcrowded housing conditions and had limited access to the Internet will encounter inequitable access to health care during the pandemic.

In addition, the authors found that people between the ages of 18 and 40 have the highest rate of infection in Los Angeles County; in New York, people over age 45 are most affected. Men in both regions have higher rates of infection than women.

Source: Read Full Article

Top virologist to power two countries for a new Corona-rise of responsible

The Corona-pandemic keeps the world in suspense: More than 15 million people have been infected with the Coronavirus, 204.397 of them in Germany. The United States reported almost daily new record numbers.

Top virologist to power two countries for a new Corona-rise of responsible

19.39 PM: In many States is, according to the Robert Koch Institute (RKI), a significant increase in reported Coronavirus cases to observe. "This is a very worrying development is from RKI very closely beobachtet", the way explained to the RKI on it.

A Trend that is also Top-of-the virologist Alexander Kekulé followed, with concern. Many of the New infections had to do with private parties, or leisure behavior. The virologist has two Federal States in the visor: "We now have seen a slight increase of about four, five days. And in the last two days, it went with the new cases is significantly high. What is special is that we are not each of the outbreak, but it is so, that the two main provinces are: North Rhine-Westphalia and Baden-Württemberg", he said compared to the NDR. "This is of course harder to get a grip on to, as if there is infections in a place, such as in a hospital gibt", so Kekulé, more.


Further information for Coronavirus, you can find in the News Ticker.

Sawtooth-the summer is coming to a head: Only 36 degrees – then the drop in temperature follows

The Weather Channel saw-tooth-the summer rapidly coming to a head: Only 36 degrees – then follows the drop in temperature

Chloroquine: Malaria drug does not inhibit Coronavirus Naturopathy naturopathy specialist portal

Chloroquine does not help against SARS-CoV-2

The Malaria drug chloroquine was considered as the bearer of hope against COVID-19. It has been used for the treatment of patients with COVID-19 and in clinical studies. By now, most professional recommend people to this treatment. A new study shows that chloroquine blocks the SARS-CoV-2 infection of lung cells.

The Malaria drug chloroquine was one of many professionals for a long time the most promising drug candidates in the search for a COVID-19-therapy. But months ago, Researchers reported in the journal “The Lancet” that the drug is likely to be for the treatment of COVID-19-Ill-possibly even the death rate increases. Now, there are new insights to the preparation.

Approved drugs tested

Already more than 600,000 people worldwide have fallen by the Coronavirus SARS-CoV-2 caused disease COVID-19 to the victim. In order to obtain as quickly as possible is an effective therapy for COVID-19, are currently being tested drugs that are already used for the treatment of other diseases.

The current message according to the Department of infection biology of the German Primate center (DPZ) – Leibniz Institute for Primate research in Göttingen, Germany together with colleagues could not show at the Charité in Berlin, that the Malaria drug chloroquine which has been shown to inhibit the SARS-CoV-2 infection of kidney cells of Green monkeys (monkey), is able to prevent infection of human lung cells with the novel Coronavirus.

Therefore, chloroquine does not inhibit the spread of the Virus in the lungs is likely and should not be used for the treatment of COVID-19 used. The results of the study, which was conducted in cooperation with the Charité in Berlin and the Rheinischen Friedrich-Wilhelms-University of Bonn have been published in the scientific magazine “Nature”.

Different routes of Entry into the host cells

As the communication explains, it is known that SARS-CoV-2 is able to use different routes of Entry into the host cells. On the one hand, the pathogen can coalesce after deposition of the cells directly with the membrane and its genetic material into the host cell infiltration, on the other hand, the Virus can enter through Invagination of the host cell membrane and Budding of transport structures, called Endosomes, into the Interior of the cells.

In both cases, the attachment of the Virus to the cells, and the subsequent admission by the Spike-mediated Protein of the Coronavirus. According to the figures, the Spike needs to be activated-Protein either by the enzyme Cathepsin L (in Endosomes) or by the enzyme TMPRSS2 (at the cell surface). Depending on the cell type, both enzymes or only one of them can stand for the activation.

Agent acts only cell-type-specific

Chloroquine is a medicine used for the treatment of Malaria. Because the drug inhibits the infection of monkey kidney cells with SARS-CoV-2, chloroquine, was tested as a possible candidate for the treatment of COVID-19 in clinical studies. How the drug inhibits the infection of monkey kidney cells, however, was unclear.

The current study shows that chloroquine inhibits the Virus entry into these cells, probably by inhibition of Cathepsin L. This has raised the question of whether chloroquine also inhibits the infection of lung cells, by which it is known that they produce, although TMPRSS2, but only a little Cathepsin L.

According to the researchers, it was demonstrated that chloroquine inhibits the SARS-CoV-2 entry into human lung cells and the subsequent spread of the Virus in these cells.

“We were able to show in this study that chloroquine acts only specific to the cell type and the infection of lung cells is not blocked. This means that in the future testing of potential COVID-19-drugs from the outset, care should be taken that relevant cell lines not be used for the investigations in order not to lose time unnecessarily, and to identify as quickly as possible, effective therapeutics,“ says Stefan Pöhlmann, head of the Department of infection biology at the DPZ.

He adds: “The COVID-19 disease is caused primarily by the infection of lung cells, for this reason, these cells should have efficacy tests always take priority.” (ad)

Authors and source of information

COVID-19: CBD protects against lethal pneumonia Naturopathy naturopathy specialist portal

Protective effect of CBD in COVID-19

Cannabidiol (CBD) seems to be the occurring cytokine storm and the excessive lung inflammation in severe COVID-19-disorders counteract. CBD may even make negative changes of the lung by COVID-19 undo.

In the current study, the Augusta University, it was found that CBD could affect the treatment results in severe COVID-19-cases, a positive effect. The study was published in the English magazine “Cannabis and Cannabinoid Research”.

ARDS is one of the main causes of death in COVID-19

The Acute Respiratory Distress Syndrome (ARDS or Acute respiratory distress syndrome) in severe cases of some viral infections of the respiratory tract, including COVID-19, one of the main causes of death. There is an urgent need for better Intervention and treatment strategies, is therefore, the researchers describe.

What, exactly, ARDS is?

In acute respiratory distress syndrome is a rapid, severe infection of the lungs, which leads to a widespread inflammation, shortness of breath, rapid breathing and insufficient oxygen supply in the body and brain. Shortness of breath or difficulty in breathing are some of the early signs of COVID-19. ARDS is one of the main causes of death in infections with the Coronavirus SARS-CoV-2.

What CBD is?

CBD is available without a prescription and is used for the treatment of seizures, Parkinson’s and other diseases in which pain and/or inflammation play an important role. It is obtained from the hemp plant. Other research has already shown that the calming effect of CBD can have a positive effect on inflammation.

CBD helps the lungs to recover

Laboratory studies indicate that pure CBD of the lung can be caused help to recover from the inflammation and the cytokine storm, which by the COVID-19 Virus. By treatment with CBD in the body is healthier, oxygen can be values, report the researchers.

CBD reduced inflammation-promoting cytokines

In the new study, the applied model makes use of the large, unique genetic structure of the novel Coronavirus. It’s classic symptoms of ARDS, such as, for example, the destructive simulated immune response. CBD reduced in the model, Pro-inflammatory cytokines. As a result, the oxygen content is improved in the blood and the lung was allowed to recover from structural damage.

SARS-CoV-2 alters the lung

A major problem with SARS-CoV-2 is that the exaggerated immune response, the lungs quickly become unusable. The lung is altered so that the Virus will continue increasing, instead of the body with oxygen and to eliminate potentially harmful gases such as carbon dioxide.

High mortality rate for mechanical ventilation

Mechanical ventilation devices can take over these vital functions for a while and allow critically ill people to use less energy to Breathe and have more energy for fighting infection, while the lungs recover, in the ideal case, explain the researchers. However, there is evidence that 30 to 50 per cent of the COVID-19 affected people do not survive in spite of mechanical ventilation.

What was the impact of the treatment with CBD?

The researchers studied the lung function in mice, by analyzing the content of Pro-inflammatory cytokines, the oxygen content in the blood before and after treatment, as well as the temperature. By treatment with CBD, the Oxygen levels increased and inflammation and cytokine values were. In a later analysis of the lung, a reduction in the key indicators for destructive inflammation could be observed.

How successful is the treatment of mice was that?

The mice were treated in a process developed, the mimic should be what happens in people in treatment if they develop respiratory complaints, and probably medical help would take. CBD led to a rapid improvement of clinical symptoms. Later, detailed studies of the lung showed that the damage to your structure, such as tissue growth, scarring, and swelling, were also abated in whole or in part.

Physical changes have been undone

In fact, both the clinical symptoms and the physical changes in the lungs had been made as a result of ARDS, treatment with CBD reversed, report the researchers.

Further research is needed

An earlier use of the CBD could, however, lead to an impairment of proper immune response against the Virus, the Team explains. In the next steps, the research group is planning similar studies in other COVID-19 affected organs, including the intestine, heart and brain. In addition, further investigations are needed to identify the optimal dosage and the right time to the initiation of the treatment with CBD. (as)

Authors and source of information

Coronavirus: Physical distancing may help ease burden on hospitals, but only to a point

Scientists have found that longer periods of social distancing alone are not successful when it comes to slowing COVID-19 spread, an advance which may help make better decisions in countries where a second wave of the pandemic is expected.

“Conventional wisdom was, the more intense and long-term the social distancing, the more you will curb the disease spread,” said Rajan Chakrabarty, a co-author of the study from Washington University in St. Louis in the US.

According to the study, published in the journal Chaos, any strategy that involves social distancing requires other steps be taken in tandem.

“But that is true if you have social distancing implemented with contact tracing, isolation and testing. Without those, you will give rise to a second wave,” Chakrabarty said.

Payton Beeler, another co-author of the study, noted that if social distancing is the only measure taken, it must be implemented extremely carefully in order for its benefits to be fully realized.

Their epidemiological model used data gathered by Johns Hopkins University in the US between March 18 and March 29, a period marked by a rapid surge in COVID-19 cases and the onset of social distancing in most US states. Calibrating the model using these datasets allowed the authors to analyse unbiased results that had not yet been affected by large-scale distancing in place, they said.

The model also included details on how much people of different age groups interact, and how that affects the spread of transmission.

“Had social distancing been implemented earlier, we probably would’ve done a better job,” Chakrabarty said.

Over the short-term, more distancing and less hospital demand go hand in hand, the scientists said, adding that this is only up to two weeks. After that, they said the time spent distancing does not benefit hospital demand as much. Society would have to increase social distancing time exponentially in order to see a linear decrease in hospital demand, the researchers noted.

They said this leads to diminishing returns. Society would see smaller and smaller benefits to hospital demand the longer it spent social distancing, the scientists explained.

According to the researchers, if social distancing “alone” is to be implemented longer than two weeks, a moderate shut down, say between 50-70 per cent, could be more effective for the society than a stricter complete shut-down in yielding the largest reduction in medical demands.

Another strategy for flattening the curve involves acting intermittently, alternating between strict social distancing and no distancing to alleviate the strain on hospitals, the study noted. According to the model, the most efficient distancing- to- no-distancing ratio is five to one, meaning one day of no distancing for every five days at home. Had society acted in this way, the researchers said the hospital burden could have been reduced by 80 per cent. “Bending the curve using social distancing alone is analogous to slowing down the front of a raging wildfire without extinguishing the glowing embers,” said Chakrabarty.

“They are waiting to start their own fires once the wind carries them away,” he said, adding however that his team’s model cannot inform strategies going forward as it used data collected in March. But Chakrabarty added that it may be able to inform our actions if we find ourselves in a similar situation in the future.

“Next time, we must act faster, and be more aggressive when it comes to contact tracing and testing and isolation,” Chakrabarty said.

(This story has been published from a wire agency feed without modifications to the text. Only the headline has been changed.)

Follow more stories on Facebook and Twitter

Source: Read Full Article

Ethical recommendations for triage of COVID-19 patients

An international expert group led by Mathias Wirth, professor of systematic theology and ethics at the University of Bern, has developed recommendations for avoiding triage of COVID-19 patients in extreme situations. The recommendations should support medical personnel in difficult decisions during a second wave of the infection and ensure better patient care.

“A lack of intensive care ventilation units owing to rapidly increasing infection rates numbers among the most significant nightmare scenarios of the corona pandemic,” says Mathias Wirth, head of the Ethics Department in the Faculty of Theology at the University of Bern, because: “Shortages of supply can result in triage of patients suffering from severe cases of COVID-19 and thus force a life or death decision.” Here, triage means favoring some COVID-19 patients over others depending on urgency and prognosis. Together with experts from Yale University, King’s College London, Charité Berlin and Essen University Hospital, medical ethicist Mathias Wirth has prepared a statement on these difficult decisions. The statement was published in the American Journal of Bioethics (AJOB), the most frequently cited scientific journal in the entire field of ethics.

Triage is only ethically justifiable under very specific circumstances

The experts warn against the possibility of prematurely implementing triage; even though triage allows for decisions based on fairness in extreme situations, it leads to significant strain on the affected parties, relatives and medical personnel. In order to avoid it, every effort must be made to transfer seriously ill patients to other hospitals without shortages of supply—across country borders in case of emergency, according to the authors.

In concrete terms, Mathias Wirth’s team of researchers recommend increased regional, national and even international collaboration in intensive care for COVID-19 patients in preparation for future waves of infection. “Just because triage is correct under some circumstances does not mean that it is correct under all circumstances,” says Wirth. “There is no real and legitimate triage situation as long as treatment spaces are available elsewhere.”

Negative decision requires special care

Secondly, a negative triage decision for individual people should not under any circumstances mean that their medical and psychological care is neglected. Quite the opposite: If they are deprived of a ventilator, maximum effort is required for their care and treatment, both for them and for their relatives.

Source: Read Full Article

Nothing here is under control, with emigrants, about the dramatic Corona location in Florida

You can see in the Video: A German Expat on the dramatic Coronavirus situation in Florida.

“When you see the Numbers, then you think to yourself ‘Where did all this come from?'”

The US state of Florida is a new focal point of the Coronavirus pandemic. At the beginning of July, the state recorded more than 15,000 new infections a day. This exceeds even the Figures from New York. Emigrants Alexander Stöhr, of the for years in Miami, lives, speaks in an Interview with the star about the current situation on the ground.

“At the moment, is indeed called for quarantine, because my partner may have Corona. The Problem is, but Since there’s already the first Problem is that you made the Test before ten days. There is still no result. You have the feeling that I get when I’m people I run with my dog? People with masks. You got me, people keep it and don’t know really where that came from. These large Numbers that high we were, but, for example, a different example on the West coast of Florida. Almost four weeks ago, you get the feeling that no one can keep in mind. Since I was placed in a supermarket, and a mask. It has looked at the cashier behind the counter, and, of course, had no mask. As you have noticed correctly, that the people who work there, is not in the Restaurant, the want, the need, because the employer requires it. But the keeping of it. In my opinion it is due to the political, first and foremost, here in the U.S. or in Florida.

Everything else then follows. The people believe and go out and go to the beaches, to you then didn’t more people do this. All the beaches again. These large Numbers, the aftershocks of a month or two, we will reveal everything completely naturally now. I say that it seems to me, as if nothing is under control you are trying. You talk a lot. There is every day, feel every day a press conference from the White house. The experts give an opinion and say We do, are we supposed to do, stick with it!

The policy does nothing. One has the feeling that the chaotic circumstances help it to be easy to complete in addition to the track. And then you New York have. Because we do the Job. What you have to do? For example, Florida or Arizona? Not masks, bad. You do not say anything, follow the instructions of the experts. The simply do nothing. You are now standing next to him and say I think That is wrong, that we require now to the people that you have to wear a mask. In my opinion this is utter nonsense. In Germany, for example, are all in it together. Since you have a few that are against it. But generally speaking, the policy is a model but. The all pull together, and as a result, the people: know Everything clearly. The make it. Then we do it over here. The President refuses to go out with a mask out of the house, the Vice-President also. If the are no role models for the overall population, then the flaps can’t.”

And what Berlin thinks of when he looks back on Germany?

“A little jealous I must say, because it seems to work just in Germany. I have the feeling personally, and I say many friends here who feel The same way in the news. In Europe, it works now.

Germany, Italy, Spain, France. These people, these countries were badly affected. In March, April didn’t think of that here yet, looking ahead, that could also stand as soon as these countries. The countries have now brought better under control. Since I’m a bit jealous.

You wish, actually, that I would be right now in Germany, because it is me, I think, a little better would go.”

Scientists evaluate the perspectives of zinc intake for COVID-19 prevention

Researchers from Sechenov University in collaboration with colleagues from Germany, Greece and Russia, have reviewed scientific articles on the role of zinc in the prevention and treatment of viral infections and pneumonia, with projections on those caused by SARS-CoV-2. The results were published in the International Journal of Molecular Medicine.

Zinc is necessary for normal metabolism and functioning of the reproductive, cardiovascular and nervous systems, but it is also important for the immune system, in particular for the proliferation and maturation of white blood cells (some of them are able to capture and digest microorganisms, and others to produce antibodies). In addition, zinc is involved in the regulation of inflammation. Thus, normal levels of zinc support human resistance to inflammatory and infectious diseases.

“According to the current estimates, the risk of zinc deficiency is observed in more than 1.5 billion people in the world. In Russia, deficiency of this element occurs in 20-40% of the population; in some regions it reaches 60%. Given the crucial role of zinc in regulation of immunity, one can propose that its insufficiency may be considered as a risk factor for infectious diseases,” said the research leader, head of the Laboratory of Molecular Dietetics at Sechenov University, Professor Anatoly Skalny.

The scientists reviewed the results of studies on the use of zinc-containing drugs for increasing immunity and preventing viral infections, including SARS-CoV-2. Previous studies showed that zinc and its binding substances can slow down the work of RNA polymerase (an enzyme that synthesizes viral RNA molecules) of coronaviruses and suppress their spread in the body. One of the substances that stimulates cellular zinc uptake, chloroquine, has already been tested on patients with SARS-CoV-2, but its strong side effects make it necessary to look for other compounds with a similar effect or use zinc separately. However, both options have not been sufficiently studied or tested yet.

Observations of the development of other viruses, such as rhinoviruses (this family includes pathogens of acute respiratory diseases), show that an increase in the level of zinc in cells suppresses replication of the virus and stimulates production of interferon alpha, which has an antiviral activity.

In addition, zinc deficiency is considered as one of the risk factors for the development of pneumonia: it increases the susceptibility to infectious agents and the disease duration. Several studies show the effectiveness of zinc-containing drugs in decreasing severity and duration of symptoms and reducing the prevalence of pneumonia. However, in general, data on the use of zinc as a therapy, rather than prevention, are contradictory.

Another possible application of zinc is modulation of inflammation. Existing data show that zinc ions have an anti-inflammatory effect, reducing damage to lung tissue in pneumonia. Zinc also helps the body resist bacteria, and bacterial pneumonia frequently occurs in patients with secondary viral infections.

“A recent study conducted by scientists from the U.S. confirmed our assumptions, demonstrating the effect of zinc intake on the risk of a severe course and the need for artificial ventilation in patients with COVID-19,” said Alexey Tinkov, coauthor of the article, a leading researcher at the Laboratory of Molecular Dietetics at Sechenov University.

Source: Read Full Article